dc.contributor.author | Kahraman, Resul | |
dc.contributor.author | Sinem İplik, Elif | |
dc.contributor.author | Calhan, Turan | |
dc.contributor.author | Şahin, Abdurrahman | |
dc.contributor.author | Çakmakoğlu, Bedia | |
dc.date.accessioned | 2021-12-21T08:32:07Z | |
dc.date.available | 2021-12-21T08:32:07Z | |
dc.date.issued | 2018 | |
dc.identifier.issn | 2564-6567 | |
dc.identifier.uri | https://app.trdizin.gov.tr/makale/TWpreU9EYzBOQT09/assessment-of-the-role-of-egf-61a-g-and-egfr-r497k-polymorphism-in-patients-with-inflammatory-bowel-disease-a-case-control-study | |
dc.identifier.uri | https://doi.org/10.25000/acem.416704 | |
dc.identifier.uri | http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/948 | |
dc.description.abstract | Aim: Epidermal growth factor (EGF) and epidermal growth factor receptor (EGFR) play an important role in theregulation of cell growth, survival, migration, apoptosis, proliferation, and differentiation. We aimed toinvestigate the presence of EGF (+61A/G) | |
dc.description.abstract | Amaç: Epidermal büyüme faktörü (EGF) ve epidermal büyüme faktörü reseptörü (EGFR), hücre büyümesi,
canlılığı, migrasyonu, apoptoz, proliferasyon ve farklılaşmasının düzenlenmesinde önemli bir rol oynamaktadır.
İnflamatuar barsak hastalığı (İBH) olan hasta | |
dc.language.iso | English | |
dc.title | Assessment of the role of EGF +61A/G and EGFR R497K polymorphism in patients with inflammatory bowel disease: A case-control study | |
dc.title.alternative | İnflamatuar bağırsak hastalığında EGF +61A/G ve EGFR R497K polimorfizm rolünün değerlendirilmesi: Bir olgu-kontrol çalışması | |
dc.relation.journal | Archives of Clinical and Experimental Medicine | |
dc.identifier.issue | 2 | |
dc.identifier.startpage | 79 | |
dc.identifier.endpage | 83 | |
dc.identifier.volume | 3 | |
dc.identifier.doi | 10.25000/acem.416704 | |
dc.relation.issue | 2 | |
dc.relation.volume | 3 | |